Terms: = Lung cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Prognosis
215 results:
1. Targeted therapeutic options in early and metastatic NSCLC-overview.
Gálffy G; Morócz É; Korompay R; Hécz R; Bujdosó R; Puskás R; Lovas T; Gáspár E; Yahya K; Király P; Lohinai Z
Pathol Oncol Res; 2024; 30():1611715. PubMed ID: 38605928
[TBL] [Abstract] [Full Text] [Related]
2. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
3. prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Ohtaki Y; Nagashima T; Okano N; Kubo N; Ohtaka T; Sunaga N; Sakurai R; Miura Y; Nakazawa S; Kawatani N; Yazawa T; Yoshikawa R; Narusawa E; Shirabe K
Thorac Cancer; 2024 Apr; 15(11):859-866. PubMed ID: 38414316
[TBL] [Abstract] [Full Text] [Related]
4. Primary endobronchial melanoma: a case report and clinical management indications.
Barisione E; Boutros A; Mora M; Spagnolo F; Tanda ET; Genova C; Tagliabue E
BMC Pulm Med; 2024 Feb; 24(1):97. PubMed ID: 38402179
[TBL] [Abstract] [Full Text] [Related]
5. Is there a prognostic difference among stage I lung adenocarcinoma patients with different braf-mutation status?
Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
[TBL] [Abstract] [Full Text] [Related]
6. 2021 WHO Classification of lung cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological Features of Non-Small Cell lung Carcinoma with braf Mutation.
Ambrosini-Spaltro A; Rengucci C; Capelli L; Chiadini E; Calistri D; Bennati C; Cravero P; Limarzi F; Nosseir S; Panzacchi R; Valli M; Ulivi P; Rossi G
Curr Oncol; 2023 Nov; 30(11):10019-10032. PubMed ID: 37999148
[TBL] [Abstract] [Full Text] [Related]
8. [Research Progress of braf Fusion in Non-small Cell lung cancer].
Xiao P; Zhong D
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):782-788. PubMed ID: 37989341
[TBL] [Abstract] [Full Text] [Related]
9. Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer.
Wang X; Zhou Y; Ning L; Chen J; Chen H; Li X
Cell Death Dis; 2023 Sep; 14(9):588. PubMed ID: 37666806
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of prognostic nomogram for T
Mei W; Yao W; Song Z; Jiao W; Zhu L; Huang Q; An C; Shi J; Yu G; Sun P; Zhang Y; Shen J; Xu C; Yang H; Wang Q; Zhu Z
BMC Cancer; 2023 Jul; 23(1):715. PubMed ID: 37525124
[TBL] [Abstract] [Full Text] [Related]
11. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
[TBL] [Abstract] [Full Text] [Related]
12. [Expert consensus on the diagnosis and treatment in advanced non-small cell lung cancer with braf mutation in China].
Lung Cancer Professional Committee of Chinese Anti-Cancer Association
Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):279-290. PubMed ID: 37078209
[TBL] [Abstract] [Full Text] [Related]
13. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract] [Full Text] [Related]
14. Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases.
Fassi E; Mandruzzato M; Zamparini M; Bianchi S; Petrelli F; Baggi A; Alberti A; Grisanti S; Berruti A
Lung Cancer; 2023 May; 179():107176. PubMed ID: 37015149
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological features and genomic analysis of bronchiolar adenoma.
Bo J; Chen X; Zhang T; Zhu X; Zhang L; Liu Y; Zhang H; Wu C; Mou S; Yi X; Rui W; Zeng Y
Histol Histopathol; 2023 Dec; 38(12):1465-1474. PubMed ID: 36988010
[TBL] [Abstract] [Full Text] [Related]
16. Characteristics of Metastatic and Nonmetastatic Pulmonary Sclerosing Pneumocytomas: A Clinicopathological Study of 68 Cases and 15 Reported Metastatic Cases.
Wang X; Ng CS; Shi X; Yin W
Lab Invest; 2023 Jul; 103(7):100135. PubMed ID: 36966952
[TBL] [Abstract] [Full Text] [Related]
17. Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?
Garcia-Carbonero R; Anton-Pascual B; Modrego A; Del Carmen Riesco-Martinez M; Lens-Pardo A; Carretero-Puche C; Rubio-Cuesta B; Soldevilla B
Endocr Rev; 2023 Jul; 44(4):724-736. PubMed ID: 36879384
[TBL] [Abstract] [Full Text] [Related]
18. braf V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.
Ricco G; Seminerio R; Andrini E; Malvi D; Gruppioni E; Altimari A; Zagnoni S; Campana D; Lamberti G
Anticancer Drugs; 2023 Nov; 34(10):1076-1084. PubMed ID: 36847048
[TBL] [Abstract] [Full Text] [Related]
19. Spontaneous Murine Model of Anaplastic Thyroid cancer.
Yan H; Ma Y; Zhou X; He Y; Liu Y; Caulin C; Wang L; Xu H; Luo H
J Vis Exp; 2023 Feb; (192):. PubMed ID: 36804915
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathological features of patients with RET fusion-positive non-small cell lung cancer].
Tan Q; Ji Y; Wang XL; Wang ZW; Qi XW; Liu YK
Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):124-128. PubMed ID: 36748131
[No Abstract] [Full Text] [Related]
[Next]
